Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection

Blood

Volumn 112, Issue 10, 2008, Pages 3995-4002

  Bartman, Melissa T ^a,b   Kaidarova, Zhanna ^b   Hirschkorn, Dale ^b   Sacher, Ronald A ^c   Fridey, Joy ^d   Garratty, George ^e   Gibble, Joan ^e   Smith, James W ^f   Newman, Bruce ^e   Yeo, Anthony E ^b   Murphy, Edward L ^b,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e AMERICAN RED CROSS BLOOD SERVICES   (United States)

^f Oklahoma Blood Institute   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD DONOR; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNE RESPONSE; LONG TERM CARE; LYMPHOCYTE COUNT; MALE; MEAN CORPUSCULAR VOLUME; MONOCYTE; PRIORITY JOURNAL; RACE; SEX DIFFERENCE; T CELL LEUKEMIA; THROMBOCYTE COUNT; TIME; TRANSACTIVATION; VIRUS INFECTION;

ADULT; AGED; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIESIS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; RISK FACTORS; TIME FACTORS;

EID: 61849099313     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-155960     Document Type: Article

References (50)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77: 7415-7419.
2. Kalyanaraman VS, Sarngadharan MG, Robert- Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982;218:571-573.
3. Poiesz BJ, Ruscetti F, Reitz M, Kalyanaraman V, Gallo R. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature. 1981;294: 268-271.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79: 2031-2035.
5. Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1992;117:933-946.
6. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet. 1986;1:1031-1032.
7. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Japan J Cancer Res. 1992;83:236-239.
8. Manns A, Hisada M, La Grenade L. Human Tlymphotropic virus type I infection. Lancet. 1999; 353:1951-1958.
9. Hirata T, Uchima N, Kishimoto K, et al. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg. 2006; 74:246-249.
10. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004;6:144-154.
11. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992;326:375-380.
12. Ho GY, Nelson K, Nomura AM, Polk BF, Blattner WA. Markers of health status in an HTLV-I-positive cohort. Am J Epidemiol. 1992;136:1349- 1357.
13. Welles SL, Mueller N, Tachibana N, et al. Decreased eosinophil numbers in HTLV-I carriers. Lancet. 1991;337:987.
14. Murphy EL, Wilks R, Morgan OS, et al. Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort. Int J Epidemiol. 1996;25:1090-1097.
15. Welles SL, Tachibana N, Orav EJ, Okayama A, Ishizaki J, Mueller NE. Changes in hematologic parameters among Japanese HTLV-I carriers. J Acquir Immune Defic Syndr. 1994;7:92-97.
16. Murphy EL, Glynn S, Watanabe K, et al. Laboratory test differences associated with HTLV-I and HTLV-II infection: retrovirus Epidemiology Donor Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:332-338.
17. Prince HE. American blood donors seropositive for human T-lymphotropic virus types I/II exhibit normal lymphocyte subsets. Transfusion. 1990; 30:787-790.
18. Glynn SA, Murphy EL, Wright DJ, Sacher RA, Fridey J, Schreiber GB. Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2: a prospective analysis. Arch Pathol Lab Med. 2000;124:550- 555.
19. Murphy EL, Glynn SA, Fridey J, et al. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors: Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect Dis. 1997;176:1468-1475.
20. Kwaan N, Lee TH, Chafets DM, et al. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006;194:1557-1564.
21. Itoyama Y, Minato S, Kira J, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 1988;38:1302-1307.
22. Prince H, Kleinman S, Doyle M, Lee H, Swanson P. Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection. J Acq Immune Defic Syndr. 1990;3:1199-1200.
23. Murphy EL, Wang B, Sacher RA, et al. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004;10:109-116.
24. Asquith B, Zhang Y, Mosley AJ, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A. 2007;104:8035-8040.
25. Kondo R, Higuchi M, Takahashi M, et al. Human T-cell leukemia virus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line. Retrovirology (http://www.retrovirology.com/content/ 3/1/88). 2006;3:88.
26. Niinuma A, Higuchi M, Takahashi M, et al. Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus. J Virol. 2005;79:11925-11934.
27. Cantrell D, Smith K. The interleukin-2 T-cell system: a new cell growth model. Science. 1984; 224:1312-1316.
28. Yamano Y, Nagai M, Brennan M, et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virusspecific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood. 2002;99:88-94.
29. Grassmann R, Aboud M, Jeang K. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005;24:5976-5985.
30. Drexler HG, Quentmeier H. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia. 1996;10:1405- 1421.
31. Majka M, Ratajczak J, Villaire G, et al. Thrombopoietin, but not cytokines binding to gp130 protein- coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Exp Hematol. 2002;30:751-760.
32. Mori N, Shirakawa F, Shimizu H, et al. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type Iinfected T-cell lines: evidence for the involvement of NF-kappa B. Blood. 1994;84:2904-2911.
33. Yamashita I, Katamine S, Moriuchi R, et al. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood. 1994;84:1573-1578.
34. Fauci A. Host factors and the pathogenesis of HIV-induced disease. Nature. 1996;384:529-534.
35. Franchini A, Malagoli D, Ottaviani E. Cytokines and invertebrates: TGF-beta and PDGF. Curr Pharm Des. 2006;12:3025-3031.
36. Millette E, Rauch B, Kenagy R, Daum G, Clowes A. Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med. 2006;16:25-28.
37. Murphy EL, Glynn SA, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors: Retrovirus Epidemiology Donor Study. Arch Intern Med. 1999;159: 1485-1491.
38. Murphy EL, Ownby HE, Smith JW, et al. Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study. BMC Pulm Med (http://www.biomedcentral.com/1471-2466/3/1/). 2003;3:1.
39. Eisenstaedt R, Penninx B, Woodman R. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006;20:213-226.
40. Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer. 2006;46: 554-557.
41. DelaRosa O, Pawelec G, Peralbo E, et al. Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology. 2006;7:471-481.
42. Pawelec G, Barnett Y, Forsey R, et al. T cells and aging, January 2002 update. Front Biosci. 2002; 7:d1056-1183.
43. Pawelec G. Immunosenescence comes of age: symposium on aging research in immunology: the impact of genomics. EMBO Rep. 2007;8:220- 223.
44. Whitehead T, Robinson D, Allaway S, Hale A. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clin Lab Haematol. 1995;17:131-138.
45. Nordin G, Mårtensson A, Swolin B, et al. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest. 2004;64:385- 398.
46. Nakanishi N, Yoshida H, Okamoto M, Matsuo Y, Suzuki K, Tatara K. Association of alcohol consumption with white blood cell count: a study of Japanese male office workers. J Intern Med. 2003;253:367-374.
47. Welles SL, Tachibana N, Okayama AM, et al. The distribution of T-cell subsets among HTLV-I carriers in Japan. J Acquir Immune Defic Syndr. 1994; 7:509-516.
48. Hisada M, Okayama A, Tachibana N, et al. Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan. Int J Cancer. 1998;77:188-192.
49. Brown E, Brown B, Yeager M, et al. Haplotypes of IL6 and IL10 and susceptibility to human T lymphotropic virus type I infection among children. J Infect Dis. 2006;194:1565-1569.
50. Goedert J, Li H, Gao X, et al. Risk of human Tlymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer. 2007;121:1092-1097.